{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:54:40Z","timestamp":1771044880331,"version":"3.50.1"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Patients with chronic lung diseases, such as cystic fibrosis, were considered a risk group for a severe course of coronavirus disease 2019 at the beginning of the pandemic. However, mounting evidence suggests that this group may not face an elevated risk for a severe SARS-CoV-2 infection. Methods: Here, we present data on the incidence and clinical course of SARS-CoV-2 infections in a single pediatric CF centre in Austria. Clinical variables were analyzed for their potential impact on disease acquisition and severity. A total of 135 young people with CF were assessed from February 2020 until December 2022. Results: Eighty-four patients were infected with SARS-CoV-2, out of which nine patients reported re-infection, resulting in 93 SARS-CoV-2 infections. Most infections, 76\/93 (82%), occurred during the period of omicron variant predominance. Higher body mass index and respiratory colonization with Haemophilus influenzae before the beginning of the pandemic were significantly associated with the risk of acquiring SARS-CoV-2 infection. All patients had an uncomplicated COVID-19 course, regardless of the SARS-CoV-2 variant and COVID-19 vaccine status at infection. The most frequent symptoms were rhinitis (53%), fatigue (49%), cephalea (43%), and fever (38%). Neither oxygen therapy nor hospitalization were needed for any of the patients. Lung function parameters (FEV1, FVC, FEF50, LCI), both in the early post-viral as well as late post-viral stages, were not significantly impacted by SARS-CoV-2 infections. No long-term post-COVID-19 effects were reported. Conclusions: Our single-centre experience suggests that the course of SARS-CoV-2 infections in children and adolescents with CF is primarily mild and uncomplicated.<\/jats:p>","DOI":"10.3390\/jcm14092979","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:57:47Z","timestamp":1745571467000},"page":"2979","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uncomplicated SARS-CoV-2 Infections with Preserved Lung Function in Pediatric Patients with Cystic Fibrosis: A Three-Year Single-Centre Experience"],"prefix":"10.3390","volume":"14","author":[{"given":"Justyna","family":"Sieber","sequence":"first","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9867-4447","authenticated-orcid":false,"given":"Nicole","family":"Martin","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-4798","authenticated-orcid":false,"given":"Klara","family":"Schmidthaler","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Gaupmann","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Dehlink","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-2658","authenticated-orcid":false,"given":"Alexandra","family":"Graf","sequence":"additional","affiliation":[{"name":"Institute of Medical Statistics, Centre for Medical Data Science, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Sz\u00e9pfalusi","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-6640","authenticated-orcid":false,"given":"Saskia","family":"Gruber","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy and Endocrinology, Department of Pediatrics and Adolescent Medicine, Comprehensive Centre of Pediatrics, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024, December 12). Situation Update Coronavirus Disease (COVID-19) Pandemic. Available online: https:\/\/www.who.int\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jcf.2007.12.002","article-title":"The role of respiratory viruses in cystic fibrosis","volume":"7","author":"Wat","year":"2008","journal-title":"J. Cyst. Fibros."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1183\/09031936.00202311","article-title":"Viral infections trigger exacerbations of cystic fibrosis in adults and children","volume":"40","author":"Wark","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"Flight","year":"2014","journal-title":"Thorax"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2011.06.004","article-title":"Impact of the A (H1N1) pandemic influenza (season 2009\u20132010) on patients with cystic fibrosis","volume":"10","author":"Viviani","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Renk, H., Regamey, N., and Hartl, D. (2014). Influenza A(H1N1)pdm09 and cystic fibrosis lung disease: A systematic meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0078583"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey","volume":"170","year":"2020","journal-title":"Respir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","article-title":"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis","volume":"19","author":"Cosgriff","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Corvol, H., de Miranda, S., Lemonnier, L., Kemgang, A., Reynaud Gaubert, M., Chiron, R., Dalphin, M.L., Durieu, I., Dubus, J.C., and Houdouin, V. (2020). First Wave of COVID-19 in French Patients with Cystic Fibrosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113624"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/ppul.26644","article-title":"SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge","volume":"58","author":"Gartner","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/infdis\/jiac328","article-title":"Omicron wave modifies the COVID-19 paradigm in children with cystic fibrosis","volume":"227","author":"Thouvenin","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jcf.2024.03.006","article-title":"COVID-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions","volume":"23","author":"Ciciriello","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ppul.26528","article-title":"Seroprevalence and clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis","volume":"58","author":"Hergenroeder","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.prrv.2013.01.007","article-title":"Ageing in cystic fibrosis and long-term survival","volume":"14","author":"Simmonds","year":"2013","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/QCO.0b013e32834748ff","article-title":"Infection prevention and control in cystic fibrosis","volume":"24","author":"Saiman","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.14423\/SMJ.0000000000001140","article-title":"Cystic Fibrosis and COVID-19","volume":"113","author":"Chapman","year":"2020","journal-title":"South. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.20452\/pamw.15630","article-title":"Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes","volume":"130","author":"Marcinkiewicz","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41467-023-35862-0","article-title":"SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation","volume":"14","author":"Bezzerri","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"100689","DOI":"10.1016\/j.nmni.2020.100689","article-title":"Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome","volume":"35","author":"Earhart","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Touret, F., Gilles, M., Barral, K., Nougair\u00e8de, A., van Helden, J., Decroly, E., de Lamballerie, X., and Coutard, B. (2020). In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-70143-6"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcf.2024.07.019","article-title":"Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study","volume":"23","author":"Semenchuk","year":"2024","journal-title":"J. Cyst. Fibros."},{"key":"ref_24","first-page":"e62821","article-title":"Clinical Outcomes Following SARS-CoV-2 Infection in Pediatric Cystic Fibrosis Patients","volume":"16","author":"Huang","year":"2024","journal-title":"Cureus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5339\/qmj.2023.19","article-title":"The clinical features and impact of SARS-CoV-2\/COVID-19 infection in children with Cystic Fibrosis (CF): A Qatari experience","volume":"2023","author":"Hamad","year":"2023","journal-title":"Qatar Med. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e13913","DOI":"10.1111\/pai.13913","article-title":"Limited role of children in transmission of SARS-CoV-2 virus in households\u2014Immunological analysis of 26 familial clusters","volume":"34","author":"Sieber","year":"2023","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.06.00100805","article-title":"Evaluating the \u201cLeeds criteria\u201d for Pseudomonas aeruginosa infection in a cystic fibrosis centre","volume":"27","author":"Proesmans","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1183\/20734735.012717","article-title":"The Global Lung Function Initiative (GLI) Network: Bringing the world\u2019s respiratory reference values together","volume":"13","author":"Cooper","year":"2017","journal-title":"Breathe"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s15010-021-01737-z","article-title":"Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: A study within the Italian Cystic Fibrosis Society","volume":"50","author":"Colombo","year":"2022","journal-title":"Infection"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naehrlich","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"00411-2021","DOI":"10.1183\/23120541.00411-2021","article-title":"Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe","volume":"7","author":"Jung","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/cid\/ciac333","article-title":"Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People with Cystic Fibrosis","volume":"75","author":"Corvol","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.jcf.2022.06.006","article-title":"Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study","volume":"21","author":"Carr","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study","volume":"20","author":"Bain","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2021055765","DOI":"10.1542\/peds.2021-055765","article-title":"Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021","volume":"149","author":"Forrest","year":"2022","journal-title":"Pediatrics"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Demirhan, S., Goldman, D.L., and Herold, B.C. (2023). Differences in the Clinical Manifestations and Host Immune Responses to SARS-CoV-2 Variants in Children Compared to Adults. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010128"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kiedrowski, M.R., and Bomberger, J.M. (2018). Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.03067"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jcf.2020.04.011","article-title":"Influenza B outbreak at an adult cystic fibrosis centre\u2014Clinical impact and factors influencing spread","volume":"19","author":"Dennis","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pulmoe.2020.10.013","article-title":"Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis","volume":"27","author":"Burgos","year":"2021","journal-title":"Pulmonology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12931-021-01834-5","article-title":"Lung function and breathing patterns in hospitalised COVID-19 survivors: A review of post-COVID-19 Clinics","volume":"22","author":"Stockley","year":"2021","journal-title":"Respir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"106276","DOI":"10.1016\/j.rmed.2020.106276","article-title":"Clinical status and lung function 10 weeks after severe SARS-CoV-2 infection","volume":"176","author":"Smet","year":"2021","journal-title":"Respir. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1473-3099(20)30371-6","article-title":"Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: A cross-sectional study","volume":"20","author":"Dorward","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13128","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e052777","DOI":"10.1136\/bmjopen-2021-052777","article-title":"Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: A systematic review and meta-analysis of observational studies","volume":"11","author":"Fiolet","year":"2021","journal-title":"BMJ Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e129880","DOI":"10.5812\/aapm-129880","article-title":"Relationship Between BMI and Disease Severity in COVID-19 Patients","volume":"12","author":"Moezzi","year":"2022","journal-title":"Anesth. Pain Med."},{"key":"ref_46","first-page":"236","article-title":"Haemophilus influenzae is associated with fibrotic phenotype of COVID-19 and idiopathic pulmonary fibrosis","volume":"8","author":"Shivshankar","year":"2022","journal-title":"ERJ Open Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Saliu, F., Rizzo, G., Bragonzi, A., Cariani, L., Cirillo, D.M., Colombo, C., Dacc\u00f2, V., Girelli, D., Rizzetto, S., and Sipione, B. (2021). Chronic infection by nontypeable Haemophilus influenzae fuels airway inflammation. ERJ Open Res., 7.","DOI":"10.1101\/2020.05.25.107995"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rumpf, C., Lange, J., Schwartbeck, B., and Kahl, B.C. (2021). Staphylococcus aureus and Cystic Fibrosis-A Close Relationship. What Can We Learn from Sequencing Studies?. Pathogens, 10.","DOI":"10.3390\/pathogens10091177"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Imperlini, E., and Papa, R. (2022). Clinical Advances in Cystic Fibrosis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216306"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Carnovale, V., Scial\u00f2, F., Gelzo, M., Iacotucci, P., Amato, F., Zarrilli, F., Celardo, A., Castaldo, G., and Corso, G. (2022). Cystic Fibrosis Patients with F508del\/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor\/Tezacaftor\/Ivacaftor Treatment. J. Clin. Med., 11.","DOI":"10.3390\/jcm11236900"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Dagenais, R.V.E., Su, V.C.H., and Quon, B.S. (2020). Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10010023"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Fayad, D., and Frenck, R.W. (2023). COVID-19 Vaccines in Children. J. Clin. Med., 13.","DOI":"10.3390\/jcm13010087"},{"key":"ref_53","unstructured":"Federal Ministry of Social Affairs, Health, Care and Consumer Protection (2022, December 12). Austria: COVID-19 National Strategy, Available online: https:\/\/healthsystemsfacts.org\/national-health-systems\/the-mixed-beveridge-bismarck-model\/austria\/austria-covid-19-strategy\/."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2571912","DOI":"10.1155\/2021\/2571912","article-title":"Value of the Neutrophil-Lymphocyte Ratio in Predicting COVID-19 Severity: A Meta-analysis","volume":"2021","author":"Wang","year":"2021","journal-title":"Dis. Markers"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Parthasarathi, A., Padukudru, S., Arunachal, S., Basavaraj, C.K., Krishna, M.T., Ganguly, K., Upadhyay, S., and Anand, M.P. (2022). The Role of Neutrophil-to-Lymphocyte Ratio in Risk Stratification and Prognostication of COVID-19: A Systematic Review and Meta-Analysis. Vaccines, 10.","DOI":"10.3390\/vaccines10081233"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/2979\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:21:40Z","timestamp":1760030500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/2979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14092979"],"URL":"https:\/\/doi.org\/10.3390\/jcm14092979","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}